Use of enzyme-inducing antiseizure meds may increase long-term cardiovascular disease risk
(HealthDay)—There appears to be a dose-dependent risk for incident cardiovascular disease associated with enzyme-inducing antiseizure medications (eiASMs), according to a
Read more